Journal of Current Glaucoma Practice

Register      Login

VOLUME 6 , ISSUE 3 ( September-December, 2012 ) > List of Articles

REVIEW ARTICLE

The Need to maintain Intraocular Pressure over 24 Hours

Parul Ichhpujani

Keywords : Diurnal variation, Fluctuation, Intraocular pressure, Phasing

Citation Information : Ichhpujani P. The Need to maintain Intraocular Pressure over 24 Hours. J Curr Glaucoma Pract 2012; 6 (3):120-123.

DOI: 10.5005/jp-journals-10008-1118

License: CC BY-NC 4.0

Published Online: 01-12-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Glaucoma patients who appear to be stable based on daytime in-clinic intraocular pressure (IOP) measurements may not be fully controlled over each 24-hour period. Given that there is sufficient evidence that IOP fluctuation may impact progression, the aim of management of glaucoma thus, is to achieve a target IOP with minimal diurnal fluctuation.


PDF Share
  1. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 1998;126:487-97.
  2. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal- Tension Glaucoma Study Group. Am J Ophthalmol 1998; 126:498-505.
  3. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol 2000;130:429-40.
  4. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13; discussion 829-30.
  5. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: The early manifest glaucoma trial. Arch Ophthalmol 2003;121:48-56.
  6. Leske MC, Heijl A, Hyman L, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007;114:1965-72.
  7. Miglior S, Torri V, Zeyen T, et al. Intercurrent factors associated with the development of open-angle glaucoma in the European Glaucoma Prevention Study. Am J Ophthalmol 2007;144: 266-75.
  8. Shirakashi M, Iwata K, Sawaguchi S, et al. Intraocular pressuredependent progression of visual field loss in advanced primary open-angle glaucoma: A 15-year follow-up. Ophthalmologica 1993;207:1-5.
  9. Anderson DR, Drance SM, Schulzer M. Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma. Am J Ophthalmol 2003;136:820-29.
  10. Asrani S, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 2000;9:134-42.
  11. Bengtsson B, Heijl A. Diurnal IOP fluctuation: Not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol 2005;243:513-18.
  12. Bengtsson B, Heijl A. A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J Glaucoma 2005;14:135-38.
  13. Bengtsson B, Leske MC, Hyman L, et al. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology 2007;114:205-09.
  14. Bergea B, Bodin L, Svedbergh B. Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology 1999;106:997-1004; discussion -5.
  15. Caprioli J, Coleman AL. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology 2008;115:1123-29 e3.
  16. Collaer N, Zeyen T, Caprioli J, Sequential office pressure measurements in the management of glaucoma. J Glaucoma 2005;14:196-200.
  17. Hattenhauer MG, Johnson DH, Ing HH, et al. The probability of blindness from open-angle glaucoma, Ophthalmology 1998;105:2099-104.
  18. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: Results from the early manifest glaucoma trial. Arch Ophthalmol 2002;120:1268-79.
  19. Hong S, Seong GJ, Hong YJ. Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure. Arch Ophthalmol 2007;125:1010-13.
  20. Inatani M, Iwao K, Inoue T, et al. Long-term relationship between intraocular pressure and visual field loss in primary open-angle glaucoma. J Glaucoma 2008;17:275-79.
  21. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108:1943-53.
  22. Martinez-Bello C, Chauhan BC, Nicolela MT, et al. Intraocular pressure and progression of glaucomatous visual field loss. Am J Ophthalmol 2000;129:302-08.
  23. Medeiros FA, Weinreb RN, Zangwill LM, et al. Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma. Ophthalmology 2008;115: 934-40.
  24. Miglior S, Pfeiffer N, Torri V, et al. Predictive factors for openangle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 2007;114:3-9.
  25. Musch DC, Gillespie BW, Lichter PR, et al. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology 2009;116:200-07.
  26. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 2004;111:1627-35.
  27. Oliver JE, Hattenhauer MG, Herman D, et al. Blindness and glaucoma: A comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol 2002;133:764-72.
  28. Sultan MB, Mansberger SL, Lee PP. Understanding the importance of IOP variables in glaucoma: A systematic review. Surv Ophthalmol 2009;54:643-62.
  29. Varma R, Hwang LJ, Grunden JW, et al. Using diurnal intraocular pressure fluctuation to assess the efficacy of fixedcombination latanoprost/timolol versus latanoprost or timolol monotherapy. Br J Ophthalmol 2010;94:80-84.
  30. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 2004;363:1711-20.
  31. Zeimer RC, Wilensky JT, Gieser DK, et al. Association between intraocular pressure peaks and progression of visual field loss. Ophthalmology 1991;98:64-69.
  32. Singh K, Shrivastava A. Intraocular pressure fluctuations: How much do they matter? Curr Opin Ophthalmol 2009;20:84-87.
  33. Morgan WH, Chauhan BC, Yu DY, et al. Optic disc movement with variations in intraocular and cerebrospinal fluid pressure. Invest Ophthalmol Vis Sci 2002;43:3236-42.
  34. Flammer J, et al. A blood test for glaucoma diagnosis. Paper presented at: The International Congress of Eye Research; October 10, 2002; Geneva, Switzerland.
  35. Bagga H, Liu JH, Weinreb RN. Intraocular pressure measurements throughout the 24 hours. Curr Opin Ophthalmol 2009;20:79-83.
  36. Realini T, Weinreb RN, Wisniewski SR. Diurnal intraocular pressure patterns are not repeatable in the short-term in healthy individuals. Ophthalmology 2010;117:1700-04.
  37. Realini T, Weinreb RN, Wisniewski S. Short-term repeatability of diurnal intraocular pressure patterns in glaucomatous individuals. Ophthalmology 2011;118:47-51.
  38. Magacho L, Toscano DA, Freire G, Shetty RK, Ávila MP. Comparing the measurement of diurnal fluctuations in intraocular pressure in the same day versus over different days in glaucoma. Eur J Ophthalmol 2010;20(3):542-45.
  39. Daubs JG. Patterns of diurnal variation in the intraocular pressure of airline pilots. Aerosp Med 1973;44:914-17.
  40. De Venecia G, Davis MD. Diurnal variation of intraocular pressure in the normal eye. Arch Ophthalmol 1963;69:752-57.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.